Chesham-based Flomark Ltd, has secured £300,000 in funding as it looks to accelerate the development of its solutions aimed at making IV drips safer for patients.
The startup has received a £150,000 investment from British Design Fund (BDF) and £150,000 from Imperial College Enterprise Fund (ICEF) as part of a broader funding round.
It is looking to transform the way fluid balance is monitored in healthcare settings. The company’s technology aims to address critical gaps in patient care by providing accurate data on infusion flow rates and urine output, which are currently difficult to measure reliably.
Flomark’s patented technology makes it possible to see at a glance how fast fluid is flowing through it and entering a patient, saving nurses time and supporting the more accurate delivery of fluids.
The Royal College of Art spinout will also use the investment to support the launch of its first product later this year.
“The idea for our product came from years spent on hospital wards during my career as a design researcher in healthcare,” said Jonathan West, co-founder of Flomark.
“I noticed that gravity infusions were often inaccurate, and fluid balance management was generally poor. This inspired me to dedicate my career to designing solutions that could make a real difference in patient care.”
Damon Bonser, CEO of British Design Fund, added: “Flomark’s innovative approach to solving a critical healthcare problem is exactly the type of enterprise we aim to support.
“The team’s expertise and dedication to improving patient outcomes through design and technology are truly inspiring.
“We’re excited to work closely with Flomark as they scale their business and bring their groundbreaking products to market.”
FinTech with 10m customers to move to Orange Tower in MediaCity